Table 1 The clinicopathological characteristics of patients
From: An end-to-end pancreatic anastomosis in robotic central pancreatectomy
Baseline and intraoperative data | |
 Sex (female/male), n | 5/6 |
 Age, mean ± SD (years) | 42.4 ± 14.3 |
 BMI, mean ± SD (kg/m2) | 24.1 ± 2.8 |
 ASA(I/II), n | 1/10 |
 Tumor size, mean ± SD (cm) | 3.4 ± 1.1 |
 Pancreatic duct diameter, mean ± SD (mm) | 2.4 ± 0.3 |
 Defect of main pancreatic duct, mean ± SD (cm) | 4.3 ± 1.0 |
 Operative time, [median (range)] (min) | 121 (105, 199) |
 Estimated blood loss, [median (range)] (ml) | 50 (20, 100) |
 Open conversion, n (%) | 0 (0) |
Pathology | |
 Solid pseudopapillary tumor, n (%) | 6 (54.5) |
 Serous cystadenoma, n (%) | 3 (27.3) |
 Pancreatic metastasis from renal cancer, n (%) | 1 (0.09) |
 Mass-forming chronic pancreatitis, n (%) | 1 (0.09) |
 Negative margin in tumor (n) | 10 (100%) |